Have a personal or library account? Click to login
Factors Favouring the Development of Clostridium Difficile Infection in Critically Ill Patients Cover

Factors Favouring the Development of Clostridium Difficile Infection in Critically Ill Patients

The Journal of Critical Care Medicine
Volume 2 (2016): Issue 1 (January 2016)
By: Bianca-Liana Grigorescu,  Raluca Ştefania Fodor,  Adrian Dan Cioc,  Mihaly Veres,  Monica Orlandea,  Bogdan Lăzescu and  Emoke Almasy  
Open Access
|Feb 2016

References

  1. 1. Walters PR, Zuckerbraun BS. Clostridium difficile infection. Clinical Challenges and management strategies. Critical Care Nurse. 2014;34:2-35.
    Search in Google Scholar
  2. 2. Barletta JF, Sclar DA. Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients. Crit Care. 2014;18:714.10.1186/s13054-014-0714-7429382625540023
    Search in Google Scholar
  3. 3. Vindigni SM, Surawicz CM. C. difficile Infection: Changing epidemiology and management paradigms. Clin Transl Gastroenterol. 2015;6,e99 .
    Search in Google Scholar
  4. 4. Miller BA, Chen LF, Sexton DJ, Anderson DJ. Comparison of the burdens of hospital onset, healthcare facility-associated Clostridium difficile infection and of healthcare-associated infection due to methicillin-resistant Staphylococcus aureus in community hospitals. Infect Control Hosp Epidemiol. 2011;32:387-90.10.1086/65915621460491
    Search in Google Scholar
  5. 5. Vaishnavi C. Clinical spectrum & pathogenesis of Clostridium difficile associated diseases. Indian J Med Res. 2010; 131:487-99.
    Search in Google Scholar
  6. 6. McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene variant strain of Clostridium difficile. N Engl J Med. 2005;353:2433-41.10.1056/NEJMoa05159016322603
    Search in Google Scholar
  7. 7. Vecchio AL, Zacur GM. Clostridium difficile infection: an update on epidemiology, risk factors, and therapeutic options. Curr Opin Gastroenterol. 2012;28:1-9.10.1097/MOG.0b013e32834bc9a922134217
    Search in Google Scholar
  8. 8. Biswal S. Proton pump inhibitors and risk for Clostridium difficile associated diarrhea. Biomed J. 2014;37:178-83.10.4103/2319-4170.12800225116712
    Search in Google Scholar
  9. 9. Oake N, Taljaard M, Walraven C, Wilson K, Roth V, Forster AJ. The effect of hospital-acquired Clostridium difficile infection on in-hospital mortality. Arch Intern Med. 2010;170:1804-10.10.1001/archinternmed.2010.40521059973
    Search in Google Scholar
  10. 10. Poutanen SM, Simor AE. Clostridium difficile associated diarrhea in adults. CMAJ. 2004;171:51-8.10.1503/cmaj.103118943768615238498
    Search in Google Scholar
  11. 11. Voth DE, Ballard JD. Clostridium difficile toxins: Mechanisms of action and role in disease. Clin Microbiol Rev. 2005;18:247-63.10.1128/CMR.18.2.247-263.2005108279915831824
    Search in Google Scholar
  12. 12. Donskey CJ. The role of the intestinal tract as a reservoir and source for transmission of nosocomial pathogens. Clin Infect Dis. 2004;39:219-26.10.1086/42200215307031
    Search in Google Scholar
  13. 13. Pepin J, Saheb N, Coulombe MA, et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: A cohort study during an epidemic in Quebec. Clin Infect Dis. 2005;41:1254-60.10.1086/49698616206099
    Search in Google Scholar
  14. 14. Neal KR, Scott HM, Slack RCB, Logan RFA. Omeprazole as a risk factor for campylobacter gastroenteritis: case control study. BMJ 1996;321:414-5.10.1136/bmj.312.7028.414
    Search in Google Scholar
  15. 15. Williams C. Occurrence and significance of gastric colonization during acid-inhibitory therapy. Best Pract Res Clin Gastroenterol. 2001;15:511-21.10.1053/bega.2001.0191
    Search in Google Scholar
  16. 16. Linsky A, Gupta K, Lawler EV, Fonda JR, Hermos JA. Proton pump inhibitors and risk for recurrent Clostridium difficile infection. Arch Intern Med. 2010;170:772-8.10.1001/archinternmed.2010.73
    Search in Google Scholar
  17. 17. Klingensmith ME, Neville LL, Delpire E, Wolfe MM, Soybel DI. Gastrin-mediated effects of omeprazole on rat colon mucosa. Surgery. 1999;126:272-8.10.1016/S0039-6060(99)70165-0
    Search in Google Scholar
  18. 18. Liebensten Z, Wenisch C, Patruta S, Parschalk B, Daxbock F, Garninger W. Omeprazole treatment diminishes intra- and extra-cellular neutrophil reactive oxygen production and bacterial activity. Crit Care Med. 2002;30:1118-22.10.1097/00003246-200205000-0002612006811
    Search in Google Scholar
  19. 19. Dial S, Delaney JAC, Barkun AN, Suissa S. Use of gastric acid-suppressive agents and the risk of communityacquired Clostridium difficile-associated disease. JAMA. 2005;294:2989-95.10.1001/jama.294.23.298916414946
    Search in Google Scholar
  20. 20. MacLaren R, Reynolds PM, Allen RR. Histamine-2 Receptor Antagonists vs Proton Pump Inhibitors on Gastrointestinal Tract Hemmorhage and Infectious Complications in the Intensive Care Unit FREE. JAMA Intern Med. 2014;174:564-74.10.1001/jamainternmed.2013.1467324535015
    Search in Google Scholar
  21. 21. Dubberke ER, Reske KA, Yan Y, Olsen MA, MacDonald LC, Fraser VJ. Clostridium difficile-associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis. 2007;45:1543-9.10.1086/52358218190314
    Search in Google Scholar
DOI: https://doi.org/10.1515/jccm-2016-0006 | Journal eISSN: 2393-1817 | Journal ISSN: 2393-1809
Journal RSS Feed
Language: English
Page range: 38 - 43
Submitted on: Jun 23, 2015
|
Accepted on: Oct 22, 2015
|
Published on: Feb 9, 2016
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
nosocomial infection,
Clostridium difficile,
Pantoprazole,
antibiotic therapy
Related subjects:
Medicine,
Clinical medicine,
Anaesthesiology,
Emergency medicine and intensive-care medicine,
Internal medicine,
Internal medicine, other,
Surgery,
Surgery, other

© 2016 Bianca-Liana Grigorescu, Raluca Ştefania Fodor, Adrian Dan Cioc, Mihaly Veres, Monica Orlandea, Bogdan Lăzescu, Emoke Almasy, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 2 (2016): Issue 1 (January 2016)Next article